(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb ...

For decades now, scientists have hypothesized that a flare-up of EBV may somehow be triggering the onset of MS. Now, a new study, led by researchers at the University of California San Francisco (UCSF ...

Over 95% of the world's adult population is infected with Epstein-Barr virus (EBV), but most people never realize it. The infection often causes few symptoms and then stays in the body for life.

Most people have the Epstein-Barr (EBV) virus. Sometimes people are unaware of this virus in their body; it settles into immune cells and remains for the duration.

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Researchers at the University Hospital ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

Ebvallo is one of a series of rare disease treatments recently turned back by the FDA amid shifting guidance that has ...

Researchers are progressing towards a vaccine against Epstein-Barr virus (EBV), which affects 95% of the global population ...

Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV), a virus believed to infect about 95% of people worldwide. EBV has been linked ...

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common ...

Nearly 95% of the global population is infected with Epstein-Barr virus, with some ‌populations at higher ⁠risk for serious ⁠complications if the virus becomes activated.